NCT00313547View on ClinicalTrials.gov

High-Dose Quinapril Versus Low-Dose Quinapril Plus Amlodipine in the Treatment of High-Risk Hypertensive Patients

PHASE4TerminatedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

April 30, 2007

Study Completion Date

March 31, 2008

Conditions
Hypertension
Interventions
DRUG

Quinapril 40 mg

DRUG

Quinapril 10 mg and amlodipine 5 mg

Trial Locations (1)

H1T 1C8

Montreal Heart Institute, Montreal

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Montreal Heart Institute

OTHER